全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 164524-93-0 | 1-(3,4-Dihydro-2H-1,4-thiazin-5-yl)ethanone | C6H9NOS |
| 164579-32-2 | Pantoprazole sodium hydrate;6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt hydrate (2:2:3) | 2(C16H14F2N3NaO4S).3(H2O) |
| 164650-44-6 | Efinaconazole;(alphaR,betaR)-alpha-(2,4-Difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol; KP 103; KP 103 (pharmaceutical) | C18H22F2N4O |
| 164656-23-9 | Dutasteride;(5alpha,17beta)-N-{2,5-Bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide | C27H30F6N2O2 |
| 164658-13-3 | CGP 60474;3-[[4-[2-[(3-Chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-1-propanol | C18H18ClN5O |
| 164666-07-3 | 3-(Methylthio)-1-pyrrolidinecarboxylic acid tert-butyl ester | C10H19NO2S |
| 164666-68-6 | 3-Amino-6-chloro-2-picoline;3-Amino-6-chloro-2-methylpyridine | C6H7ClN2 |
| 164670-44-4 | 4-Pyridylthiourea | C6H7N3S |
| 164724-35-0 | N4,N4,N4',N4'-Tetrakis([1,1'-biphenyl]-4-yl)-[1,1'-biphenyl]-4,4'-diamine;N,N,N',N'-Tetrakis([1,1'-biphenyl]-4-yl)-[1,1'-biphenyl]-4,4'-diamine; 4,4'-Bis[bis(4-biphenylyl)amino]biphenyl; N,N,N',N'-Tetra(4-biphenylyl)benzidine; N,N,N',N'-Tetrakis(biphenyl-4-yl)benzidine | C60H44N2 |
| 164726-80-1 | 4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineethanol dihydrochloride | C19H23ClN2O.2(HCl) |
| 164784-87-6 | Ethyl 2-oxopiperazine-1-acetate;2-Oxo-1-piperazineacetic acid ethyl ester | C8H14N2O3 |
| 164790-68-5 | 4-Chloro-2,6-difluorophenol | C6H3ClF2O |
| 164858-78-0 | (R)-(+)-2-[2-(Diphenylphosphino)phenyl]-4-isopropyl-2-oxazoline;(4R)-(+)-4,5-Dihydro-2-(2'-(diphenylphosphino)phenyl)-4-isopropyloxazole | C24H24NOP |
| 164861-52-3 | 2-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-N,N,N',N '-tetramethyluronium hexafluorophosphate;HDBTU | C12H16N5O2.PF6 |
| 164916-63-6 | cis-1-Benzyl-3,4-pyrrolidinedicarboxylic acid | C13H15NO4 |
| 164918-61-0 | N-Bromoisocyanuric acid monosodium salt;1-Bromo-1,3,5-triazine-2,4,6(1H,3H,5H)-trione sodium salt | C3HBrN3NaO3 |
| 164926-88-9 | 1-Methyl-4-piperidineacetonitrile | C8H14N2 |
| 164931-83-3 | (S,S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride | C36H52ClCrN2O2 |
| 164991-67-7 | Kukoamine B | C28H42N4O6 |
| 164991-86-0 | Orcinol gentiobioside | C19H28O12 |
| 165047-23-4 | 2-Chloro-4,5-difluorobenzaldehyde | C7H3ClF2O |
| 165047-24-5 | 2,4,5-Trifluorobenzaldehyde | C7H3F3O |
| 165049-28-5 | N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester 4-methylbenzenesulfonate | C24H29N5O6.C7H8O3S |
| 165111-46-6 | 2-Bromomethyl-4-cyano-benzoic acid methyl ester;Methyl 2-bromomethyl-4-cyanobenzoate | C10H8BrNO2 |
| 165112-03-8 | 2-Methylquinolin-7-ol;7-Hydroxy-2-methylquinoline | C10H9NO |
| 165115-73-1 | 2-[2-(2,4-Difluorophenyl)-2-propen-1-yl]-1,3-propanediol | C12H14F2O2 |
| 165120-40-1 | N4-Butyl-2-chloro-3,4-quinolinediamine;3-Amino-4-butylamino-2-chloroquinoline; N'-Butyl-2-chloroquinoline-3,4-diamine | C13H16ClN3 |
| 165124-42-5 | 5-Methyl-2(1H)-pyrazinone hydrazone | C5H8N4 |
| 165187-24-6 | 2-Chloro-3-formylbenzonitrile;2-Chloro-3-cyanobenzaldehyde | C8H4ClNO |
| 165190-76-1 | 4,7-Bis(thien-2-yl)-2,1,3-benzothiadiazole;4,7-Di(thiophen-2-yl)benzo[c][1,2,5]thiadiazole; 4,7-Di(thiophene-2-yl)-2,1,3-benzothiadiazole; 4,7-Di-2-thienyl-2,1,3-benzothiadiazole; NSC 701994 | C14H8N2S3 |
| 165250-69-1 | 4-Methyl-5-nitro-1H-indole | C9H8N2O2 |
| 165252-70-0 | Dinotefuran;1-Methyl-2-nitro-3-(tetrahydro-3-furylmethyl)guanidine | C7H14N4O3 |
| 165253-29-2 | 3-(Bromomethyl)tetrahydrofuran;3-(Bromomethyl)oxolane; 3-Tetrahydrofurylmethyl bromide; Tetrahydro-3-furanylmethyl bromide | C5H9BrO |
| 165253-31-6 | 3-Aminomethyltetrahydrofuran;N-(3-Tetrahydrofurylmethyl)amine; Tetrahydro-3-furanmethanamine | C5H11NO |
| 165273-06-3 | trans-4-Methyl-DL-proline ethyl ester;(4S)-rel-4-Methyl-D-proline ethyl ester | C8H15NO2 |
| 165315-26-4 | Ritonavir EP Impurity I;2-Desisopropyl-2-ethyl Ritonavir;1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-5-[[(2S)-2-[[(2-ethyl-1,3-thiazol-4-yl)methyl-methylcarbamoyl]amino]-3-methylbutanoyl]amino]-3-hydroxy-1,6-diphenylhexan-2-yl]carbamate | C36H46N6O5S2 |
| 165377-44-6 | 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine hydrochloride | C23H32N2O2.2(HCl) |
| 165393-06-6 | Urolithin C;3,8,9-Trihydroxy-6H-dibenzo[b,d]pyran-6-one; 3,8,9-Trihydroxy-6H-benzo[c]chromen-6-one; 3,8,9-Trihydroxyurolithin | C13H8O5 |
| 165450-17-9 | Neotame;N-(N-(3,3-Dimethylbutyl)-L-alpha-aspartyl)-L-phenylalanine 1-methyl ester | C20H30N2O5 |
| 165454-06-8 | 8-Benzyloxycarbonylamino-3,6-dioxaoctanoic acid;2-[2-(Cbz-amino)ethoxy]ethoxyacetic acid | C14H19NO6 |
| 165522-16-7 | 2-Chloro-4-nitrophenyl O-alpha-D-glucopyranosyl-(1→4)-O-alpha-D-glucopyranosyl-(1→4)-beta-D-glucopyranoside | C24H34ClNO18 |
| 165528-81-4 | 4-(2-Boc-aminoethyl)piperidine | C12H24N2O2 |
| 165534-43-0 | 3-(Diethoxyphosphoryloxy)-1,2,3-benzotrizin-4(3H)-one;DEPBT | C11H14N3O5P |
| 165535-45-5 | N'''-[P,P-Bis(dimethylamino)-N-ethylphosphinimyl]-N,N,N',N',N'',N''-hexamethylphosphorimidic triamide;P2Et phosphazene | C12H35N7P2 |
| 165538-40-9 | Terutroban;(R)-6-[[(4-Chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-2-methyl-1-naphthalenepropanoic acid; Triplion | C20H22ClNO4S |
| 165547-79-5 | 4-Chloro-2-hydroxy-3-nitropyridine;4-Chloro-3-nitro-1H-pyridin-2-one | C5H3ClN2O3 |
| 165617-59-4 | 4,8-Dibromobenzo[1,2-c:4,5-c']bis[1,2,5]thiadiazole-6-S(IV);4,8-Dibromo-2lambda4delta2-benzo[1,2-c:4,5-c']bis[1,2,5]thiadiazole; 4,8-Dibromobenzo[1,2-c;4,5c']bis[1,2,5]thiadiazole; NSC 681081 | C6Br2N4S2 |
| 165660-09-3 | 4-(trans-4-Pentylcyclohexyl)benzoic acid (1S)-1-phenyl-1,2-ethanediyl ester;S 1011; S 1011 (chiral dopant); ZLI 4571 | C44H58O4 |
| 165660-27-5 | Hydroxy Naphthol Blue disodium salt | C20H12N2Na2O11S3 |
| 165668-41-7 | Indisulam;N-(3-Chloro-1H-indol-7-yl)-1,4-benzenedisulfonamide | C14H12ClN3O4S2 |